Антибиотики и Химиотерапия (Oct 2021)

Problem of Drug Interactions in the Treatment of Patients with COVID-19 and Comorbid Conditions

  • R. M. Aramisova,
  • Z. A. Kambachokova,
  • Z. A. Akhkubekova,
  • L. L. Logvina,
  • M. M. Sarbasheva,
  • S. M. Chudopal,
  • L. B. Tlapshokova,
  • L. M. Taukenova,
  • A. R. Tambiev,
  • K. R. Pshukov

DOI
https://doi.org/10.37489/0235-2990-2021-66-7-8-45-49
Journal volume & issue
Vol. 66, no. 7-8
pp. 45 – 49

Abstract

Read online

The article discusses the issues of drug interactions in the treatment of COVID-19 patients with concomitant cardiovascular diseases. It was revealed, that the most frequent comorbid background in patients with COVID-19 is cardiac pathology. Cardiac arrhythmias are observed in many cases, which can be aggravated by the proarrhythmogenic effect of drugs used to treat the novel coronavirus disease.

Keywords